Sponsor

Mallinckrodt

Clinical research sponsor

Published trials36
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

36 shown
Registry to Evaluate INOmax in Newborn Babies With Pulmonary HypertensionNCT03132428 · lead sponsor · 2017-07-27
TERMINATED
Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid ArthritisNCT02919761 · lead sponsor · 2016-11-07
COMPLETED
Observational Registry of Acthar Gel for Participants With Multiple Sclerosis RelapseNCT02633033 · lead sponsor · 2015-11-24
COMPLETED
Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac SurgeryNCT01959828 · lead sponsor · 2013-09-01
COMPLETED
Acthar for Treatment of Proteinuria in Diabetic Nephropathy PatientsNCT01601236 · lead sponsor · 2012-05-01
COMPLETED
Assessing Relapse in Multiple Sclerosis (ARMS) QuestionnaireNCT01547351 · lead sponsor · 2011-12-01
COMPLETED
Inhaled Nitric Oxide (INO) In Hypoxic Respiratory FailureNCT00922532 · lead sponsor · 2009-11-01
WITHDRAWN
Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator TestingNCT00626028 · lead sponsor · 2004-09-01
COMPLETED
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid ArthritisNCT00221000 · lead sponsor · 2003-08-01
COMPLETED
The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) ImplantationNCT00060840 · lead sponsor · 2003-07-01
COMPLETED
Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric OxideNCT00041574 · lead sponsor · 2002-04-01
TERMINATED
Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid ArthritisNCT01579890 · lead sponsor
APPROVED_FOR_MARKETING
Inhaled Nitric Oxide for ARDS-related Pulmonary HypertensionNCT06249633 · collaborator · 2024-02-01
UNKNOWN
Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary DysplasiaNCT03576885 · collaborator · 2019-07-15
TERMINATED
The Effects of Acthar on Synovial Inflammation in Rheumatoid ArthritisNCT03511625 · collaborator · 2018-10-02
UNKNOWN
Registry of Preterm Newborns With Severe Pulmonary HypertensionNCT03310346 · collaborator · 2017-08-01
COMPLETED
Use of Acthar in Rheumatoid Arthritis (RA) Related FlaresNCT02541955 · collaborator · 2017-07-20
COMPLETED
Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar GelNCT03082573 · collaborator · 2017-03-03
UNKNOWN
Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MSNCT02446886 · collaborator · 2016-06-01
TERMINATED
Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory FailureNCT01891500 · collaborator · 2016-05-01
WITHDRAWN
ACTH for Fatigue in Multiple Sclerosis PatientsNCT02315872 · collaborator · 2015-05-22
COMPLETED
ACTH Gel Therapy in Rheumatoid ArthritisNCT02030028 · collaborator · 2014-11-01
COMPLETED
Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple SclerosisNCT02296346 · collaborator · 2014-10-01
TERMINATED
ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to MethotrexateNCT01984268 · collaborator · 2014-06-23
TERMINATED
ACTH in Progressive Forms of MSNCT01950234 · collaborator · 2014-04-17
TERMINATED
Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid ArthritisNCT02434757 · collaborator · 2014-02-01
UNKNOWN
Comprehensive Analysis of Relapse in Multiple SclerosisNCT01906684 · collaborator · 2013-08-01
UNKNOWN
Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS RelapsesNCT01900093 · collaborator · 2013-07-01
UNKNOWN
Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic SurgeryNCT01783236 · collaborator · 2013-06-01
COMPLETED
A Trial of Neuroprotection With ACTH in Acute Optic NeuritisNCT01838174 · collaborator · 2013-05-01
TERMINATED
Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) MethylprednisoloneNCT00947895 · collaborator · 2009-10-01
TERMINATED
Modeling and Treating the Pathophysiology of Demyelination in Multiple SclerosisNCT00854750 · collaborator · 2009-05-01
TERMINATED
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)NCT01028287 · collaborator · 2009-05-01
COMPLETED
The Magnetic Resonance Imaging Evaluation of Doxorubicin CardiotoxicityNCT00530101 · collaborator · 2004-07-01
COMPLETED
Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary HypertensionNCT00023296 · collaborator · 2001-07-27
COMPLETED
Early Inhaled Nitric Oxide for Respiratory Failure in NewbornsNCT00005773 · collaborator · 1998-08-01
TERMINATED

Sponsor roles

collaborator24
lead sponsor12

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.